How COVID-19 induces cytokine storm with high mortality

Area of Science:

• Immunology
• Virology
• Pathology

Background:

• COVID-19, caused by SARS-CoV-2, has led to a global health crisis.
• Severe cases often develop acute respiratory distress syndrome (ARDS), characterized by high mortality.
• ARDS in COVID-19 is linked to a cytokine storm, a hyperinflammatory response.

Purpose of the Study:

• To review the pathogenic mechanisms of ARDS in COVID-19.
• To identify potential therapeutic targets for managing ARDS and cytokine storm in COVID-19.
• To explore the role of IL-6-STAT3 signaling as a therapeutic target.

Main Methods:

• Review of existing literature on COVID-19 pathogenesis.
• Analysis of the cytokine storm mechanism, focusing on IL-6 and NF-κB pathways.
• Examination of IL-6-STAT3 signaling in non-immune cells during inflammation.

Main Results:

• The cytokine storm in severe COVID-19 involves hyper-activation of the IL-6 amplifier.
• Simultaneous activation of IL-6-STAT3 and NF-κB signaling in alveolar epithelial and endothelial cells contributes to ARDS.
• IL-6 is identified as a key stimulator of STAT3, particularly in inflammatory conditions.

Conclusions:

• Targeting IL-6-STAT3 signaling presents a promising therapeutic avenue for mitigating the cytokine storm in COVID-19-induced ARDS.
• Understanding the molecular pathways of ARDS is crucial for developing effective treatments.
• Further research into IL-6-STAT3 inhibition could lead to improved patient outcomes.